Patient Implant Cards: Which Implantable Devices Need a Card and What It Must Show

1. Key takeaways

The legal source for the Australian patient implant card is Essential Principles clause 13A.2 (Patient implant cards etc. for implantable devices), which applies to all implantable and active implantable devices. The exempted categories are sutures, staples, dental fillings, dental braces, dental crowns, screws, wedges, plates, wires, pins, clips, connectors, or similar items. The character height on the card must be no less than 1 mm. In practical terms, any implantable product that is not on the exemption list must ship with a card that satisfies the content, language and character-height requirements, and devices that fall within the UDI scope must carry the identifiers on the card as well. The obligation therefore sits at the intersection of patient information, labelling and UDI compliance, and it is best managed under a single design control. The four mandatory content items are fixed by the Regulations, so the design task is layout and legibility rather than content selection, and neither the language requirement nor the character-height minimum can be delegated to a printing vendor without a written specification.

2. Legal basis

The implant card obligation sits within the patient information requirements for implantable and active implantable devices, and it interlocks with the UDI regime for devices that fall within the UDI scope. The requirements below are drawn from the Regulations and from the TGA guidance page current at the time of verification, and items three to five — the mandatory information, the UDI overlay and the format rules — are the ones that drive card design decisions. Article 45 covers the UDI regime itself; this article covers only its effect on the card.

1. Therapeutic Goods (Medical Devices) Regulations 2002 (F2002B00237, compiled version F2026C00883): Essential Principles Schedule 1, clause 13A.2 — Patient implant cards etc. for implantable devices; clauses 13A.1–13A.4 set out the patient information requirements for implantable and active implantable devices.
2. Scope: all implantable and active implantable devices; exemptions — sutures, staples, dental fillings, dental braces, dental crowns, screws, wedges, plates, wires, pins, clips, connectors, or similar items (TGA, Patient implant cards and information leaflets, 18 August 2026).
3. Mandatory information on the card: device name, model, lot code / batch number or serial number, and manufacturer name + address + website.
4. UDI overlay: devices within the UDI scope must also carry the full UDI (UDI-DI + UDI-PI, in barcode or AIDC machine-readable format) as well as the UDI-DI in HRI format.
5. Format requirements: the card must be in English (other languages may be added); it must be provided in writing and in a language the patient can understand; the character height must be no less than 1 mm; both paper and electronic formats are acceptable.
6. Timing link with UDI: implantable devices are mostly Class III or Class IIb, corresponding to the first UDI mandatory date of 1 July 2026 (see article 45 for details).

3. Expert insights

Insight 1: the exemption list is a category enumeration, not a rule that low risk means exemption. Screws, plates and wires are exempt, but more complex implants — such as spinal fusion implants or artificial joints — are not. The determination must be made category by category against the list; it cannot be inferred from the level of risk. A product team that assumes complex implants are automatically covered while simple hardware is automatically exempt will get the determination wrong in both directions. The safest method is a table that lists every implantable product against every exempted category, with the clause wording quoted in the rationale column.

Insight 2: the UDI requirements on the card are tied to the UDI mandatory dates. Devices within the UDI scope must also print the full UDI and the UDI-DI in HRI format. This means the implant card design must be revised on the UDI compliance date itself; this is not work that can be phased in gradually. Card artwork, electronic templates and the associated design records all need to be updated in the same cycle as the UDI labelling change. Scheduling them separately is what causes cards without identifiers to reach the market after the compliance date.

Insight 3: an electronic format is permitted, but the language-understandable-by-the-patient requirement remains a hard rule. An electronic card is acceptable, yet the language requirement does not soften with the change of medium. For products serving linguistically diverse populations, this means preparing multilingual versions of the card, with the mandatory English text retained even when translations are added.

4. Practical recommendations

• Maintain a list of implantable products and determine card requirements item by item against the exempted categories, recording the basis for each determination. The list should be revisited whenever a new product or a new variant is introduced.
• Design the card template around the four mandatory information items (name, model, batch or serial number, manufacturer name, address and website), reserving zones for the UDI and the HRI format, so that the identifiers can be added without redesigning the card when the UDI date arrives.
• Write the 1 mm character height into the design specification, and verify it separately for the paper and electronic media, using the final production files rather than drafts.
• Schedule the card work with the UDI project: Class III and Class IIb implantable products must complete their card revision before 1 July 2026, which in practice means artwork changes need to start well ahead of that date.

5. Verification checklist

• □ Card requirements have been determined item by item against the exempted categories
• □ The card contains the four items: name, model, batch or serial number, and manufacturer information
• □ Devices within the UDI scope carry the full UDI and the UDI-DI in HRI format
• □ Character height has been verified as no less than 1 mm
• □ The card revision is synchronised with the 1 July 2026 UDI date

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Australian market. Our team manages adverse event reporting and recall coordination with the TGA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com